Matt Niloff heads up Pall Biotech’s Integrated Solutions Program in the Americas. He began his career at MIT working on The Human Genome Project and went on to leading roles in the commercialization of singleuse technologies at Millipore, Stedim, Xcellerex GE, and Pall. Matt holds a Master of Science degree in biology from McGill University in Montreal.